Comparison of telomerase activity between malignant and tuberculous pleural effusions

Journal of the Medical Association of Thailand

Volumn 89, Issue SUPPL. 5, 2006, Pages

  Maneechotesuwan, Kittipong ^a   Lertworawiwat, Aroon ^a   Tscheikuna, Jamsak ^a   Wamanuttajinda, Valla ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Malignancy; Pleural effusion; Telomerase activity; Tuberculosis

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA FLUID; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; THORACOCENTESIS; TUBERCULOUS PLEURISY;

ADULT; AGED; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION; TELOMERASE; TUBERCULOSIS, PLEURAL;

EID: 33846700148     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Giazza G, Cosimi MF, Lanero M, Rossi GP, Casagranda I. Cytologic diagnosis and chromosome analysis: sensitivity, specificity, accuracy and predictive value in malignant and benign pleural effusions. Pathologica 1990; 82: 33-40.
2. Paganuzzi M, Onetto M, Marroni P, Filiberti R, Tassara E, Parodi S, et al. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest 2001; 119: 1138-42.
3. Villena V, Lpez-Encuentra A, Echave-Sustaeta J, Martin-Escribano P, Ortuno-de-Solo B, Estenoz-Alfaro J. Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4. Lung Cancer 2003; 40: 289-94.
4. Delahaye M, van der HF, van der Kwast TH. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions. Diagn Cytopathol 1997; 17: 115-20.
5. Dewald GW, Hicks GA, Dines DE, Gordon H. Cytogenetic diagnosis of malignant pleural effusions: culture methods to supplement direct preparations in diagnosis. Mayo Clin Proc 1982; 57: 488-94.
6. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-73.
7. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
8. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997; 17: 498-502.
9. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 1998; 16: 1217-22.
10. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998; 18: 65-8.
11. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349-52.
12. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998; 8: 279-82.
13. Braunschweig R, Yan P, Guilleret I, Delacretaz F, Bosman FT, Mihaescu A, et al. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn Cytopathol 2001; 24: 174-80.
14. Cheng CW, Chueh SC, Chern HD. Diagnosis of bladder cancer using telomerase activity in voided urine. J Formos Med Assoc 2000; 99: 920-5.
15. Hess JL, Highsmith WE Jr. Telomerase detection in body fluids. Clin Chem 2002; 48: 18-24.
16. Tangkijvanich P, Tresukosol D, Sampatanukul P, Sakdikul S, Voravud N, Mahachai V, et al. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites. Clin Cancer Res 1999; 5: 2470-5.
17. Dikmen G, Dikmen E, Kara M, Sahin E, Dogan P, Ozdemir N. Diagnostic implications of telomerase activity in pleural effusions. Eur Respir J 2003; 22: 422-6.
18. Mu XC, Brien TP, Ross JS, Lowry CV, McKenna BJ. Telomerase activity in benign and malignant cytologic fluids. Cancer 1999; 87: 93-9.
19. Braunschweig R, Guilleret I, Delacretaz F, Bosman FT, Mihaescu A, Benhattar J. Pitfalls in TRAP assay in routine detection of malignancy in effusions. Diagn Cytopathol 2001; 25: 225-30.
20. Lee WY. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination. Cytopathology 2005; 16: 227-32.
21. Barry SM, Lipman MC, Bannister B, Johnson MA, Janossy G. Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis. J Infect Dis 2003; 187: 243-50.
22. Santucci MB, Bocchino M, Garg SK, Marruchella A, Colizzi V, Saltini C, et al. Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis. Eur Respir J 2004; 24: 638-43.
23. Wang C, Li J, Zheng H, Wei H, Zhang R, Li B, Tian Z. The role of innate immune cells in the response of heat-treated Mycobacterium tuberculosis (M.tb) antigens stimulating PBMCs. Cell Mol Immunol 2004; 1: 467-70.
24. Lyadova IV, Eruslanov EB, Khaidukov SV, Yeremeev VV, Majorov KB, Pichugin AV, et al. Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease. J Immunol 2000; 165: 5921-31.
25. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-5.
26. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 1997; 90: 785-95.
27. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996; 183: 2471-9.
28. Liu K, Schoonmaker MM, Levine BL, June CH, Hodes RJ, Weng NP. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci U S A 1999; 96: 5147-52.
29. Zendehrokh N, Dejmek A. Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes. Mod Pathol 2005; 18: 189-96.
30. Giusti G, Galanti B. Adenosine deaminase. In: Bergmeyer HV, editor. Methods of enzymatic analsis. New York: Academic Press; 1983. 315-23.
31. Arai T, Yasuda Y, Takaya T, Ito Y, Hayakawa K, Toshima S, et al. Application of telomerase activity for screening of primary lung cancer in bronchoalveolar lavage fluid. Oncol Rep 1998; 5: 405-8.
32. Xinarianos G, Scott FM, Liloglou T, Prime W, Turnbull L, Walshaw M, et al. Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease. Lung Cancer 2000; 28: 37-42.
33. Dikmen E, Kara M, Dikmen G, Cakmak H, Dogan P. Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer. Eur J Cardiothorac Surg 2003; 23: 194-9.
34. Sen S, Reddy VG, Khanna N, Guleria R, Kapila K, Singh N. A comparative study of telomerase activity in sputum, bronchial washing and biopsy specimens of lung cancer. Lung Cancer 2001; 33: 41-9.
35. Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Ando K, et al. Telomerase activity in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst 1998; 90: 684-90.
36. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996; 8: 66-71.
37. Londono-Vallejo JA, Der-Sarkissian H, Cazes L, Bacchetti S, Reddel RR. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res 2004; 64: 2324-7.
38. Reddel RR. Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 2003; 194: 155-62.
39. Sheng WY, Chien YL, Wang TC. The dual role of protein kinase C in the regulation of telomerase activity in human lymphocytes. FEBS Lett 2003; 540: 91-5.
40. Yang CT, Lin MC, Huang CC, Chen NH, Chen JK. Tuberculin purified protein derivative up-regulates the telomerase activity of peripheral blood mononuclear cells from patients with pulmonary tuberculosis. Life Sci 1999; 64: 1383-91.